Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

US Patent 8492399 · Granted Jul 23, 2013

Estimated economic value: $24,562,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound2025
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of d2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024
Glycyrrhetinic acid derivatives for use in treating hyperkalemia2024
Glycyrrhetinic acid derivatives for treating hyperkalemia2023
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl2023
JAK kinase inhibitor compounds for treatment of respiratory disease2023
JAK kinase inhibitor compounds for treatment of respiratory disease2023
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-car2023
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound2023